Telomir Pharmaceuticals, Inc. (TELO) Net income 2022–2025
Telomir Pharmaceuticals, Inc. (TELO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.4MFY2025 · since FY2022: -$854,147 → -$10.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.4M | +37.0% |
| FY2024 | -$16.5M | -26.5% |
| FY2023 | -$13.1M | -1430.4% |
| FY2022 | -$854,147 | — |
Source: SEC XBRL filings · For reference only · Not investment advice